Published in Influenza Other Respir Viruses on August 09, 2012
Association between antibody titers and protection against influenza virus infection within households. J Infect Dis (2014) 1.50
Effectiveness of antiviral prophylaxis coupled with contact tracing in reducing the transmission of the influenza A (H1N1-2009): a systematic review. Theor Biol Med Model (2013) 0.91
Epidemiological characterization of influenza A(H1N1)pdm09 cases from 2009 to 2010 in Baguio City, the Philippines. PLoS One (2013) 0.81
Interpreting Seroepidemiologic Studies of Influenza in a Context of Nonbracketing Sera. Epidemiology (2016) 0.75
Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature (2005) 30.92
Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature (2009) 17.96
Comparative epidemiology of pandemic and seasonal influenza A in households. N Engl J Med (2010) 5.90
The severity of pandemic H1N1 influenza in the United States, from April to July 2009: a Bayesian analysis. PLoS Med (2009) 5.86
The Hong Kong-68 influenza A2 variant. Lancet (1968) 5.25
Protective efficacy of seasonal influenza vaccination against seasonal and pandemic influenza virus infection during 2009 in Hong Kong. Clin Infect Dis (2010) 4.81
Delaying the international spread of pandemic influenza. PLoS Med (2006) 4.50
The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong. Clin Infect Dis (2010) 3.51
School closure and mitigation of pandemic (H1N1) 2009, Hong Kong. Emerg Infect Dis (2010) 3.42
Influenza-associated mortality in Hong Kong. Clin Infect Dis (2004) 3.02
Viral load in patients infected with pandemic H1N1 2009 influenza A virus. J Med Virol (2010) 2.55
The natural viral load profile of patients with pandemic 2009 influenza A(H1N1) and the effect of oseltamivir treatment. Chest (2010) 2.48
How to maintain surveillance for novel influenza A H1N1 when there are too many cases to count. Lancet (2009) 2.44
Acceptability of A/H1N1 vaccination during pandemic phase of influenza A/H1N1 in Hong Kong: population based cross sectional survey. BMJ (2009) 2.42
Epidemiological characteristics of 2009 (H1N1) pandemic influenza based on paired sera from a longitudinal community cohort study. PLoS Med (2011) 2.26
Widespread public misconception in the early phase of the H1N1 influenza epidemic. J Infect (2009) 2.24
Human influenza virus A/HongKong/156/97 (H5N1) infection. Vaccine (1998) 2.17
Transmission parameters of the A/H1N1 (2009) influenza virus pandemic: a review. Influenza Other Respir Viruses (2011) 2.09
Entry screening to delay local transmission of 2009 pandemic influenza A (H1N1). BMC Infect Dis (2010) 2.05
Prevalence of preventive behaviors and associated factors during early phase of the H1N1 influenza epidemic. Am J Infect Control (2010) 1.98
Transmissibility of seasonal and pandemic influenza in a cohort of households in Hong Kong in 2009. Epidemiology (2011) 1.95
Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection. Clin Infect Dis (2011) 1.68
Tropism and innate host responses of the 2009 pandemic H1N1 influenza virus in ex vivo and in vitro cultures of human conjunctiva and respiratory tract. Am J Pathol (2010) 1.67
The clustering and transmission dynamics of pandemic influenza A (H1N1) 2009 cases in Hong Kong. J Infect (2011) 1.64
Community psychological and behavioral responses through the first wave of the 2009 influenza A(H1N1) pandemic in Hong Kong. J Infect Dis (2010) 1.59
Complications and outcomes of pandemic 2009 Influenza A (H1N1) virus infection in hospitalized adults: how do they differ from those in seasonal influenza? J Infect Dis (2011) 1.55
Clinical and nonclinical health care workers faced a similar risk of acquiring 2009 pandemic H1N1 infection. Clin Infect Dis (2011) 1.54
Influence of country of study on student responsiveness to the H1N1 pandemic. Public Health (2010) 1.46
Estimating infection attack rates and severity in real time during an influenza pandemic: analysis of serial cross-sectional serologic surveillance data. PLoS Med (2011) 1.46
Viral clearance and inflammatory response patterns in adults hospitalized for pandemic 2009 influenza A(H1N1) virus pneumonia. Antivir Ther (2011) 1.45
Logistical feasibility and potential benefits of a population-wide passive-immunotherapy program during an influenza pandemic. Proc Natl Acad Sci U S A (2010) 1.42
Factors affecting intention to receive and self-reported receipt of 2009 pandemic (H1N1) vaccine in Hong Kong: a longitudinal study. PLoS One (2011) 1.37
The effective reproduction number of pandemic influenza: prospective estimation. Epidemiology (2010) 1.34
Excess mortality associated with the 2009 pandemic of influenza A(H1N1) in Hong Kong. Epidemiol Infect (2011) 1.23
Pandemic (H1N1) 2009 influenza in the UK: clinical and epidemiological findings from the first few hundred (FF100) cases. Epidemiol Infect (2010) 1.23
Concurrent comparison of epidemiology, clinical presentation and outcome between adult patients suffering from the pandemic influenza A (H1N1) 2009 virus and the seasonal influenza A virus infection. Postgrad Med J (2010) 1.22
Sero-immunity and serologic response to pandemic influenza A (H1N1) 2009 virus in Hong Kong. J Med Virol (2010) 1.21
Seasonal influenza vaccination predicts pandemic H1N1 vaccination uptake among healthcare workers in three countries. Vaccine (2011) 1.19
Reflections on pandemic (H1N1) 2009 and the international response. PLoS Med (2010) 1.17
Prevention of nosocomial transmission of swine-origin pandemic influenza virus A/H1N1 by infection control bundle. J Hosp Infect (2010) 1.16
Situational awareness and health protective responses to pandemic influenza A (H1N1) in Hong Kong: a cross-sectional study. PLoS One (2010) 1.16
The influence of social-cognitive factors on personal hygiene practices to protect against influenzas: using modelling to compare avian A/H5N1 and 2009 pandemic A/H1N1 influenzas in Hong Kong. Int J Behav Med (2011) 1.15
Case fatality ratio of pandemic influenza. Lancet Infect Dis (2010) 1.14
The impact of pandemic influenza A (H1N1) 2009 on the circulation of respiratory viruses 2009-2011. Influenza Other Respir Viruses (2012) 1.12
Factors in association with acceptability of A/H1N1 vaccination during the influenza A/H1N1 pandemic phase in the Hong Kong general population. Vaccine (2010) 1.10
Seroprevalence of antibody to pandemic influenza A (H1N1) 2009 among healthcare workers after the first wave in Hong Kong. J Hosp Infect (2011) 1.07
The lower serum immunoglobulin G2 level in severe cases than in mild cases of pandemic H1N1 2009 influenza is associated with cytokine dysregulation. Clin Vaccine Immunol (2010) 1.05
A school outbreak of pandemic (H1N1) 2009 infection: assessment of secondary household transmission and the protective role of oseltamivir. Epidemiol Infect (2010) 1.00
Avoidance behaviors and negative psychological responses in the general population in the initial stage of the H1N1 pandemic in Hong Kong. BMC Infect Dis (2010) 0.98
A cost-effectiveness analysis of "test" versus "treat" patients hospitalized with suspected influenza in Hong Kong. PLoS One (2012) 0.95
High incidence of severe influenza among individuals over 50 years of age. Clin Vaccine Immunol (2011) 0.94
Characterizing the initial diffusion pattern of pandemic (H1N1) 2009 using surveillance data. PLoS Curr (2010) 0.88
Willingness to accept H1N1 pandemic influenza vaccine: a cross-sectional study of Hong Kong community nurses. BMC Infect Dis (2010) 0.87
Practical limitations of convalescent plasma collection: a case scenario in pandemic preparation for influenza A (H1N1) infection. Transfusion (2010) 0.86
Changes in knowledge, perceptions, preventive behaviours and psychological responses in the pre-community outbreak phase of the H1N1 epidemic. Epidemiol Infect (2010) 0.86
Will the community nurse continue to function during H1N1 influenza pandemic: a cross-sectional study of Hong Kong community nurses? BMC Health Serv Res (2010) 0.85
Hong Kong's experience on the use of extracorporeal membrane oxygenation for the treatment of influenza A (H1N1). Hong Kong Med J (2010) 0.84
Determinants of 2009 A/H1N1 influenza vaccination among pregnant women in Hong Kong. Matern Child Health J (2013) 0.83
Age-matched comparison of children hospitalized for 2009 pandemic H1N1 influenza with those hospitalized for seasonal H1N1 and H3N2. PLoS One (2011) 0.83
Teachers' risk perception and needs in addressing infectious disease outbreak. J Sch Nurs (2010) 0.82
Delayed oseltamivir treatment is associated with longer viral shedding of pandemic (H1N1) 2009 virus. Epidemiol Infect (2011) 0.82
Efficacy of dual vaccination of pandemic H1N1 2009 influenza and seasonal influenza on institutionalized elderly: a one-year prospective cohort study. Vaccine (2011) 0.81
Knowledge, risk perceptions, and preventive precautions among Hong Kong students during the 2009 influenza A (H1N1) pandemic. Am J Infect Control (2012) 0.80
Reconstruction of epidemic curves for pandemic influenza A (H1N1) 2009 at city and sub-city levels. Virol J (2010) 0.79
The perceptions of and disincentives for receiving influenza A (H1N1) vaccines among chronic renal disease patients in Hong Kong. Health Soc Care Community (2011) 0.78
Healthcare workers' duty concerns of working in the isolation ward during the novel H1N1 pandemic. J Clin Nurs (2011) 0.77
Another nightmare after SARS: knowledge perceptions of and overcoming strategies for H1N1 influenza among chronic renal disease patients in Hong Kong. Qual Health Res (2010) 0.77
Anti-ganglioside antibodies were not detected in human subjects infected with or vaccinated against 2009 pandemic influenza A (H1N1) virus. Vaccine (2012) 0.76
Protective efficacy of seasonal influenza vaccination against seasonal and pandemic influenza virus infection during 2009 in Hong Kong. Clin Infect Dis (2010) 4.81
Human infection with avian influenza A H7N9 virus: an assessment of clinical severity. Lancet (2013) 3.90
Comparative epidemiology of human infections with avian influenza A H7N9 and H5N1 viruses in China: a population-based study of laboratory-confirmed cases. Lancet (2013) 3.77
The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong. Clin Infect Dis (2010) 3.51
School closure and mitigation of pandemic (H1N1) 2009, Hong Kong. Emerg Infect Dis (2010) 3.42
Influenza vaccine effectiveness in the community and the household. Clin Infect Dis (2013) 3.40
Viral shedding and clinical illness in naturally acquired influenza virus infections. J Infect Dis (2010) 3.29
Influenza virus in human exhaled breath: an observational study. PLoS One (2008) 2.89
Comparative estimation of the reproduction number for pandemic influenza from daily case notification data. J R Soc Interface (2007) 2.83
Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials. BMC Med (2013) 2.65
Circulating influenza virus, climatic factors, and acute myocardial infarction: a time series study in England and Wales and Hong Kong. J Infect Dis (2011) 2.64
How to maintain surveillance for novel influenza A H1N1 when there are too many cases to count. Lancet (2009) 2.44
Effects of oseltamivir treatment on duration of clinical illness and viral shedding and household transmission of influenza virus. Clin Infect Dis (2010) 2.36
Validation and analysis of a mathematical model of a replication-competent oncolytic virus for cancer treatment: implications for virus design and delivery. Cancer Res (2003) 2.33
Epidemiological characteristics of 2009 (H1N1) pandemic influenza based on paired sera from a longitudinal community cohort study. PLoS Med (2011) 2.26
Effects of school closures, 2008 winter influenza season, Hong Kong. Emerg Infect Dis (2008) 2.18
Entry screening to delay local transmission of 2009 pandemic influenza A (H1N1). BMC Infect Dis (2010) 2.05
Influenza virus aerosols in human exhaled breath: particle size, culturability, and effect of surgical masks. PLoS Pathog (2013) 2.02
Does Glycosylation as a modifier of Original Antigenic Sin explain the case age distribution and unusual toxicity in pandemic novel H1N1 influenza? BMC Infect Dis (2010) 2.01
Transmissibility of seasonal and pandemic influenza in a cohort of households in Hong Kong in 2009. Epidemiology (2011) 1.95
Protective efficacy against pandemic influenza of seasonal influenza vaccination in children in Hong Kong: a randomized controlled trial. Clin Infect Dis (2012) 1.94
Sample size considerations for one-to-one animal transmission studies of the influenza A viruses. PLoS One (2013) 1.92
Effect of interventions on influenza A (H9N2) isolation in Hong Kong's live poultry markets, 1999-2005. Emerg Infect Dis (2007) 1.82
Optimizing the dose of pre-pandemic influenza vaccines to reduce the infection attack rate. PLoS Med (2007) 1.73
Estimating the reproduction number of the novel influenza A virus (H1N1) in a Southern Hemisphere setting: preliminary estimate in New Zealand. N Z Med J (2009) 1.70
Community psychological and behavioral responses through the first wave of the 2009 influenza A(H1N1) pandemic in Hong Kong. J Infect Dis (2010) 1.59
Obesity, physical activity, and mortality in a prospective chinese elderly cohort. Arch Intern Med (2006) 1.57
Aerosol transmission is an important mode of influenza A virus spread. Nat Commun (2013) 1.56
Excess mortality associated with influenza A and B virus in Hong Kong, 1998-2009. J Infect Dis (2012) 1.54
Clinical and nonclinical health care workers faced a similar risk of acquiring 2009 pandemic H1N1 infection. Clin Infect Dis (2011) 1.54
Surveillance of wild birds for avian influenza virus. Emerg Infect Dis (2010) 1.52
Factors affecting QuickVue Influenza A + B rapid test performance in the community setting. Diagn Microbiol Infect Dis (2009) 1.52
A chain multinomial model for estimating the real-time fatality rate of a disease, with an application to severe acute respiratory syndrome. Am J Epidemiol (2005) 1.49
Synchrony of clinical and laboratory surveillance for influenza in Hong Kong. PLoS One (2008) 1.49
The earliest notes on the reproduction number in relation to herd immunity: Theophil Lotz and smallpox vaccination. J Theor Biol (2006) 1.48
Infection fatality risk of the pandemic A(H1N1)2009 virus in Hong Kong. Am J Epidemiol (2013) 1.47
Estimating infection attack rates and severity in real time during an influenza pandemic: analysis of serial cross-sectional serologic surveillance data. PLoS Med (2011) 1.46
The state-reproduction number for a multistate class age structured epidemic system and its application to the asymptomatic transmission model. Math Biosci (2008) 1.44
Household transmission of 2009 pandemic influenza A (H1N1): a systematic review and meta-analysis. Epidemiology (2012) 1.43
Logistical feasibility and potential benefits of a population-wide passive-immunotherapy program during an influenza pandemic. Proc Natl Acad Sci U S A (2010) 1.42
Comparison of patients hospitalized with influenza A subtypes H7N9, H5N1, and 2009 pandemic H1N1. Clin Infect Dis (2014) 1.40
Nonpharmaceutical Measures for Pandemic Influenza in Nonhealthcare Settings-International Travel-Related Measures. Emerg Infect Dis (2020) 1.38
Avian influenza and ban on overnight poultry storage in live poultry markets, Hong Kong. Emerg Infect Dis (2012) 1.38
Factors affecting intention to receive and self-reported receipt of 2009 pandemic (H1N1) vaccine in Hong Kong: a longitudinal study. PLoS One (2011) 1.37
The effective reproduction number of pandemic influenza: prospective estimation. Epidemiology (2010) 1.34
Online detection and quantification of epidemics. BMC Med Inform Decis Mak (2007) 1.33
Non-parametric estimation of the case fatality ratio with competing risks data: an application to Severe Acute Respiratory Syndrome (SARS). Stat Med (2007) 1.30
A systematic review and meta-analysis of prophylactic central neck dissection on short-term locoregional recurrence in papillary thyroid carcinoma after total thyroidectomy. Thyroid (2013) 1.29
Poultry market closures and human infection with influenza A(H7N9) virus, China, 2013-14. Emerg Infect Dis (2014) 1.29
Increased risk of noninfluenza respiratory virus infections associated with receipt of inactivated influenza vaccine. Clin Infect Dis (2012) 1.28
Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review. Expert Rev Vaccines (2014) 1.25
The age-specific cumulative incidence of infection with pandemic influenza H1N1 2009 was similar in various countries prior to vaccination. PLoS One (2011) 1.23
A profile of the online dissemination of national influenza surveillance data. BMC Public Health (2009) 1.23
Research findings from nonpharmaceutical intervention studies for pandemic influenza and current gaps in the research. Am J Infect Control (2010) 1.22
Optimizing use of multistream influenza sentinel surveillance data. Emerg Infect Dis (2008) 1.21
Case fatality risk of influenza A (H1N1pdm09): a systematic review. Epidemiology (2013) 1.21
Oseltamivir for treatment and prevention of pandemic influenza A/H1N1 virus infection in households, Milwaukee, 2009. BMC Infect Dis (2010) 1.21
Identifying transmission cycles at the human-animal interface: the role of animal reservoirs in maintaining gambiense human african trypanosomiasis. PLoS Comput Biol (2013) 1.19
Estimation of the association between antibody titers and protection against confirmed influenza virus infection in children. J Infect Dis (2013) 1.18
Age-specificity of clinical dengue during primary and secondary infections. PLoS Negl Trop Dis (2011) 1.18
Human exposure to live poultry and psychological and behavioral responses to influenza A(H7N9), China. Emerg Infect Dis (2014) 1.17
Vancomycin MIC creep in MRSA isolates from 1997 to 2008 in a healthcare region in Hong Kong. J Infect (2009) 1.16
Validation of self-swab for virologic confirmation of influenza virus infections in a community setting. J Infect Dis (2011) 1.15
The influence of social-cognitive factors on personal hygiene practices to protect against influenzas: using modelling to compare avian A/H5N1 and 2009 pandemic A/H1N1 influenzas in Hong Kong. Int J Behav Med (2011) 1.15
Case fatality ratio of pandemic influenza. Lancet Infect Dis (2010) 1.14
Viral genetic sequence variations in pandemic H1N1/2009 and seasonal H3N2 influenza viruses within an individual, a household and a community. J Clin Virol (2011) 1.12